These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25838118)

  • 1. Respiratory deficits in a rat model of Parkinson's disease.
    Tuppy M; Barna BF; Alves-Dos-Santos L; Britto LR; Chiavegatto S; Moreira TS; Takakura AC
    Neuroscience; 2015 Jun; 297():194-204. PubMed ID: 25838118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the locus coeruleus catecholaminergic neurons in the chemosensory control of breathing in a Parkinson's disease model.
    Oliveira LM; Tuppy M; Moreira TS; Takakura AC
    Exp Neurol; 2017 Jul; 293():172-180. PubMed ID: 28431876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between neuroanatomical and functional respiratory changes observed in an experimental model of Parkinson's disease.
    Fernandes-Junior SA; Carvalho KS; Moreira TS; Takakura AC
    Exp Physiol; 2018 Oct; 103(10):1377-1389. PubMed ID: 30070746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orexinergic neurons are involved in the chemosensory control of breathing during the dark phase in a Parkinson's disease model.
    Oliveira LM; Falquetto B; Moreira TS; Takakura AC
    Exp Neurol; 2018 Nov; 309():107-118. PubMed ID: 30110606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory activity in the 6-hydroxydopamine model of Parkinson's disease in the rat.
    Budzinska K; Andrzejewski K
    Acta Neurobiol Exp (Wars); 2014; 74(1):67-81. PubMed ID: 24718045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The involvement of the pathway connecting the substantia nigra, the periaqueductal gray matter and the retrotrapezoid nucleus in breathing control in a rat model of Parkinson's disease.
    Lima JC; Oliveira LM; Botelho MT; Moreira TS; Takakura AC
    Exp Neurol; 2018 Apr; 302():46-56. PubMed ID: 29305892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
    J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory disturbances in a mouse model of Parkinson's disease.
    Oliveira LM; Oliveira MA; Moriya HT; Moreira TS; Takakura AC
    Exp Physiol; 2019 May; 104(5):729-739. PubMed ID: 30758090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potential target for the treatment of Parkinson's disease: effect of lateral habenula lesions.
    Han B; Jin HJ; Song MY; Wang T; Zhao H
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1191-5. PubMed ID: 25219971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory deficits in a female rat model of Parkinson's disease.
    de la Rosa T; Calvo VS; Gonçalves VC; Ferreira CB; Cabral LM; Souza FDC; Scerni DA; Scorza FA; Moreira TS; Takakura AC
    Exp Physiol; 2022 Nov; 107(11):1349-1359. PubMed ID: 36030407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
    Aponso PM; Faull RL; Connor B
    Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats.
    Liu CQ; Chen Z; Liu FX; Hu DN; Luo JH
    Neuropharmacology; 2007 Dec; 53(7):832-41. PubMed ID: 17919665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased tyrosine hydroxylase expression accompanied by glial changes within the non-lesioned hemisphere in the 6-hydroxydopamine model of Parkinson's disease.
    Schlachetzki JC; Marxreiter F; Regensburger M; Kulinich A; Winner B; Winkler J
    Restor Neurol Neurosci; 2014; 32(4):447-62. PubMed ID: 24604006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
    Alvarez-Fischer D; Henze C; Strenzke C; Westrich J; Ferger B; Höglinger GU; Oertel WH; Hartmann A
    Exp Neurol; 2008 Mar; 210(1):182-93. PubMed ID: 18053987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a new low-dose 6-hydroxydopamine model of Parkinson's disease in rat.
    Penttinen AM; Suleymanova I; Albert K; Anttila J; Voutilainen MH; Airavaara M
    J Neurosci Res; 2016 Apr; 94(4):318-28. PubMed ID: 26762168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivo.
    Saal KA; Koch JC; Tatenhorst L; Szegő EM; Ribas VT; Michel U; Bähr M; Tönges L; Lingor P
    Neurobiol Dis; 2015 Jan; 73():150-62. PubMed ID: 25283984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 6-hydroxydopamine-induced nigrostriatal neurodegeneration produces microglia-like NG2 glial cells in the rat substantia nigra.
    Kitamura Y; Inden M; Minamino H; Abe M; Takata K; Taniguchi T
    Glia; 2010 Nov; 58(14):1686-700. PubMed ID: 20629191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodology and effects of repeated intranasal delivery of DNSP-11 in a rat model of Parkinson's disease.
    Stenslik MJ; Potts LF; Sonne JW; Cass WA; Turchan-Cholewo J; Pomerleau F; Huettl P; Ai Y; Gash DM; Gerhardt GA; Bradley LH
    J Neurosci Methods; 2015 Aug; 251():120-9. PubMed ID: 25999268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and anatomical effects of quinolinic acid in the striatum of the hemiparkinsonian rat.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 2005 Jan; 55(1):26-36. PubMed ID: 15499610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.